FDA reminder letters demand missing clinical trial results The FDA sent reminder letters to more than 2,200 companies and researchers, underscoring that they are required to report clinical trial results. The trigger is noncompliance: the agency is urging follow through on trials where required…
Continue reading...
Continue reading...